Erlotinib Terminated Phase 1 / 2 Trials for Glioblastoma Multiforme (GBM) / Brain Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs